Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: Savant who wrote (3721)	9/24/2001 11:39:49 AM
From: David MacLachlan	Read Replies (2) \| Respond to of 3725

The problem with the deal, besides the price, is the fact that the conversion will be based on the future price for GE..That is, if GE goes up we get fewer shares. On the bright side management seems to only control 11% of the votes (according to the press release). The option grant to GE is a cost free way of rewarding them if their action results in a bidding war for IMAT while at the same time lowering GE's average cost if it is the winning buyer in a bidding war (if any). The key is for another bidder to show up to the party.